Indoxen

Indometacin, the active ingredient in Indoxen, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a rectal suppository for rectal use. It is indicated for rheumatoid arthritis, osteoarthritis, gout flares and other acute pain and inflammatory conditions in adults.

GNH USA supplies Indoxen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin acts as a non‑selective COX inhibitor to relieve inflammation and pain in several musculoskeletal disorders.

- Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Gout flares: diminishes acute gouty inflammation and pain. - Acute pain and inflammation: provides rapid relief of short‑term inflammatory pain.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Abdominal pain or dyspepsia. - Nausea or vomiting. - Headache. - Dizziness. - Diarrhea.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment. - Hepatic dysfunction. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or anaphylactoid reactions. - Cardiovascular events including hypertension or thrombotic episodes.

Before prescribing Indoxen, clinicians should consider several safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check serum creatinine and electrolytes regularly. - Evaluate cardiovascular status: use caution in patients with hypertension or heart disease. - Use the lowest effective dose: limit duration to the shortest necessary period. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Indometacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: reduced renal clearance leading to toxicity. - Methotrexate: enhanced toxicity, especially at high doses.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may impair renal function when combined. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Diuretics: potential for reduced potassium levels and renal effects.